What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.05%Below 5Y avg (1.15%)
Annual Rate
CNY 0.12Paid annual
Payout Ratio
42.9%Sustainable
Payback Period
93.1 yr
Last Ex-Dividend
May 25, 2026
The reported statements, read against the company's own industry.
What stands out
Earnings significantly exceed cash generation
Financials view
Market Capitalization
5.29BCNY
789.76M · vs all stocks (USD)
Updated Sep 20, 2026
Trailing P/E
40.89x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Revenue (TTM)
1.13BCNY
169.34M · vs all stocks (USD)
Updated Sep 20, 2026
Profit Margin
11.61%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Beta
0.8080x
vs all stocks
Updated Sep 20, 2026
52-Week Change
-7.21%
vs all stocks
Updated Sep 20, 2026
Market Capitalization
5.29BCNY
789.76M · vs all stocks (USD)
Updated Sep 20, 2026
Enterprise Value
4.29BCNY
640.13M · vs all stocks (USD)
Updated Sep 20, 2026
Trailing P/E
40.89x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Forward P/E
27.26x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Price to Sales (TTM)
4.66x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Price to Book (MRQ)
2.77x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Enterprise to Revenue
3.78x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Enterprise to EBITDA
31.23x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 27.51×.Updated Sep 20, 2026
Gross Margin
39.57%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 36.9%.Updated Sep 20, 2026
Profit Margin
11.61%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Operating Margin
12.18%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Return on Assets (TTM)
3.75%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Return on Equity (TTM)
7.13%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Revenue (TTM)
1.13BCNY
169.34M · vs all stocks (USD)
Updated Sep 20, 2026
Revenue per Share (TTM)
2.38CNYUpdated Sep 20, 2026
Quarterly Revenue Growth
43.30%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Gross Profit (TTM)
418.73MCNY
62.48M · vs all stocks (USD)
Updated Sep 20, 2026
EBITDA (TTM)
155.92MCNY
23.27M · vs all stocks (USD)
Updated Sep 20, 2026
Net Income (TTM)
131.77MCNY
19.66M · vs all stocks (USD)
Updated Sep 20, 2026
Quarterly Earnings Growth (YoY)
71.00%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Operating Cash Flow (TTM)
48.95MCNY
7.30M · vs all stocks (USD)
Updated Sep 20, 2026
Levered Free Cash Flow (TTM)
-122.13MCNY
-18.22M · vs all stocks (USD)
Updated Sep 20, 2026
Trailing Annual Dividend Rate
0.1200CNYUpdated Sep 20, 2026
Trailing Annual Dividend Yield
1.05%
vs all stocks
Updated Sep 20, 2026
5-Year Average Dividend Yield
1.15%
vs all stocks
Updated Sep 20, 2026
Payout Ratio
42.86%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Minority Interest (Equity)
52.44KCNYFY2025 · Dec 31, 2025
Revenue
891.10MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
537.31MCNYFY2025 · Dec 31, 2025
Gross Profit
353.80MCNYFY2025 · Dec 31, 2025
Operating Income
79.53MCNY
11.87M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
76.70MCNYFY2025 · Dec 31, 2025
Income Tax Expense
2.39MCNYFY2025 · Dec 31, 2025
Net Income
74.31MCNYFY2025 · Dec 31, 2025
EBIT
76.97MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
113.04MCNYFY2025 · Dec 31, 2025
Research & Development
143.63MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
45.22MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.66MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
13.30MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
269.08KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1600CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1600CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
465.99MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
465.99MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
74.31MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
247.56KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
35.84MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-79.08MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
144.70MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
74.31MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
-2.81MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-11.38MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-24.28MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-114.92MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-3.04BCNYFY2025 · Dec 31, 2025
Sale of Investments
3.06BCNYFY2025 · Dec 31, 2025
Other Investing Activity
6.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-89.93MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-100.57MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-3.78MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-104.35MCNYFY2025 · Dec 31, 2025
Shares Outstanding
462.24MSharesUpdated Sep 20, 2026
Float Shares
254.43MSharesUpdated Sep 20, 2026
% Held by Insiders
44.66%
vs all stocks
Updated Sep 20, 2026
% Held by Institutions
5.95%
vs all stocks
Updated Sep 20, 2026
Total Cash (MRQ)
944.65MCNY
140.96M · vs all stocks (USD)
Updated Sep 20, 2026
Total Cash per Share (MRQ)
2.07CNYUpdated Sep 20, 2026
Total Debt (MRQ)
5.53MCNY
824.65K · vs all stocks (USD)
Updated Sep 20, 2026
Total Debt to Equity (MRQ)
0.0029x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Current Ratio (MRQ)
5.74x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Book Value per Share (MRQ)
4.14CNYUpdated Sep 20, 2026
Total Assets
2.17BCNY
324.31M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.69BCNYFY2025 · Dec 31, 2025
Total Liabilities
336.83MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
487.76MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
9.75MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
327.07MCNYFY2025 · Dec 31, 2025
Cash
648.17MCNYFY2025 · Dec 31, 2025
Cash Equivalents
301.23KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
648.48MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
376.18MCNYFY2025 · Dec 31, 2025
Accounts Receivable
255.86MCNYFY2025 · Dec 31, 2025
Inventory
349.81MCNYFY2025 · Dec 31, 2025
Accounts Payable
242.51MCNYFY2025 · Dec 31, 2025
Short-term Debt
2.94MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
841.01KCNYFY2025 · Dec 31, 2025
Long-term Debt
3.65MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
459.92MCNYFY2025 · Dec 31, 2025
Retained Earnings
748.48MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.84BCNY
274.05M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
30.44MCNYFY2025 · Dec 31, 2025
52-Week Low
9.24CNYUpdated Sep 20, 2026
52-Week High
16.38CNYUpdated Sep 20, 2026
52-Week Change
-7.21%
vs all stocks
Updated Sep 20, 2026
Beta
0.8080x
vs all stocks
Updated Sep 20, 2026
50-Day MA
11.15CNYUpdated Sep 20, 2026
200-Day MA
12.74CNYUpdated Sep 20, 2026
Avg 10-Day Volume
12.69MSharesUpdated Sep 20, 2026
Avg 30-Day Volume
13.47MSharesUpdated Sep 20, 2026
Diluted EPS (TTM)
0.2800CNYUpdated Sep 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0×, lower than 95% of its Scientific & Technical Instruments peers (median 0.13×)Notable